SAVERS HEALTH AND BEAUTY LIMITED

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  +4.8%

  £754,828,000 → £791,310,000

• Cash

  +16.9%

  £61,129,000 → £71,466,000

• Net assets

  +11.9%

  £142,121,000 → £159,068,000

• Employees

  +1.5%

  5,034 → 5,110

• Operating profit

  +14.3%

  £65,238,000 → £74,554,000

• Profit before tax

  +14.2%

  £61,257,000 → £69,928,000

• Wages

  +8.9%

  £100,625,000 → £109,579,000

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

1. SAVERS HEALTH AND BEAUTY LIMITED 1996-07-26 → present
2. SAVERS DRUGSTORES PLC 1990-11-06 → 1996-07-26
3. SAVER'S DRUG STORES LIMITED 1988-03-09 → 1990-11-06
4. SOURCEPOLE LIMITED 1987-12-04 → 1988-03-09

Accounting basis

FRS 101

Reporting scope

Standalone (parent only)

Auditor

PricewaterhouseCoopers LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“The Company's forecasts and projections, taking account of reasonably possible changes in trading performance, show that the Company should be able to operate within the level of its current cash reserves and group loans for a period of a least 12 months from the date of signing these financial statements. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”

Significant events

• “On 15 April 2025, after the reporting date but before the financial statements issuance, an interim dividend of £40.0m, for the 52 weeks ended 27 December 2025 was paid to the parent company AS Watson (Health & Beauty UK) Limited.”
• “On 20 May 2025 a loan extension was agreed to extend the existing credit agreement with AS Watson Group (HK) Limited from 15 June 2025 to 15 June 2030.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

2

last 12 months

Capital events

0

last 24 months

Officers appointed

0

last 12 months

Officers resigned

0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.